K279-1015 Screening compound: N~1~-CYCLOHEXYL-3-{5-[(4-FLUOROBENZYL)SULFANYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL}PROPANAMIDE

K279-1015 Screening compound: N~1~-CYCLOHEXYL-3-{5-[(4-FLUOROBENZYL)SULFANYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL}PROPANAMIDE
K279-1015 Screening compound: N~1~-CYCLOHEXYL-3-{5-[(4-FLUOROBENZYL)SULFANYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL}PROPANAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound K279-1015
N~1~-CYCLOHEXYL-3-{5-[(4-FLUOROBENZYL)SULFANYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL}PROPANAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K279-1015

Molecular Formula

C26H27FN4O2S (C26 H27 FN4 O2 S)

Compound Name

N~1~-CYCLOHEXYL-3-{5-[(4-FLUOROBENZYL)SULFANYL]-2-OXO-2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLIN-3-YL}PROPANAMIDE

IUPAC name

n/a

SMILES

O=C(CCC1N2C(SCc(cc3)ccc3F)=Nc(cccc3)c3C2=NC1=O)NC1CCCCC1

InChI

InChI=1S/C26H27FN4O2S/c27-18-12-10-17(11-13-18)16-34-26-29-21-9-5-4-8-20(21)24-30-25(33)22(31(24)26)14-15-23(32)28-19-6-2-1-3-7-19/h4-5,8-13,19,22H,1-3,6-7,14-16H2,(H,28,32)/t22-/m0/s1

InChI Key

GHGZQBMWQDUALB-QFIPXVFZSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

478.59

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.766

Distribution Coefficient, logD

3.766

Water Solubility, LogSw

-4.16

Polar Surface Area

59.348

Acid Dissociation Constant (pKa)

10.29

Base Dissociation Constant (pKb)

3.90

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

38.50

K279-1015 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

CNS Targets (44014 compounds)

CNS targets activity set (6557 compounds)

Human GPCR Annotated Library (5539 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Nervous system

References: we are preparing a list of scientific research reports with K279-1015 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K279-1015?
Check Price and Availability of K279-1015, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K279-1015 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K279-1015
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K279-1015
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K279-1015 available by request